Case Report: Successful treatment of new onset plaque psoriasis with secukinumab in a peritoneal dialysis patient

• by Junyan Fang, Ruolin Li, Yingxin Xie, Yingli Liu

• July 8, 2026

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

• by Andrea Surnit

• July 6, 2026

• 3 min

Paradoxical inflammatory switches during biologic therapy: a mechanistic framework, clinical algorithm, and pediatric illustrations

• by Małgorzata Kowacka, Michał Dec, Hubert Arasiewicz

• May 20, 2026

Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy

• by Zeno Fratton, Stefano Bighetti, Luca Bettolini, Marina Venturini, Mariateresa Rossi, Andrea Carugno, Nicola Zerbinati, Giuseppe Stinco, Enzo Errichetti

• June 28, 2026